Please assess the completion status of the following clinical trial:

Trial Title: Tegaderm vs. EyeGard for Eye Protection

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: PREVENTION
- Time Perspective: None
- Masking: TRIPLE
- Phase: None
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~* Age ≥ 18~* Surgeries scheduled for anesthesia of any duration~Exclusion Criteria:~* Any patient that does not consent~* Any patient who has:~* Pre-existing eyelid erythema or other eyelid trauma~* Eyelid piercings~* Any surgery on the head, brain, neck, teeth, mouth, eyes or face~* Surgery in the prone position~* Patients \<18 years old

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: None
- Healthy Volunteers: t

Study Arms:
- TegadermTM on R eye, EyeGard® on L eye (Type: EXPERIMENTAL): Patients will get TegadermTM on Right eye, EyeGard® on Left eye
- TegadermTM on L eye, EyeGard® on R eye (Type: EXPERIMENTAL): Patients will get TegadermTM on Left eye, EyeGard® on Right eye

Based on this trial design, predict the completion outcome and termination type (if applicable).